Your browser doesn't support javascript.
loading
Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
Hara, Hisao; Uemura, Yukari; Hayakawa, Kayoko; Togano, Tomiteru; Asai, Yusuke; Matsunaga, Nobuaki; Terada, Mari; Ohtsu, Hiroshi; Kitajima, Koji; Shimizu, Yousuke; Sato, Lubna; Ishikane, Masahiro; Kinoshita-Iwamoto, Noriko; Shibata, Taro; Kondo, Masashi; Izumi, Kazuo; Sugiura, Wataru; Ohmagari, Norio.
Afiliação
  • Hara H; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan. Electronic address: hhara@hosp.ncgm.go.jp.
  • Uemura Y; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Hayakawa K; Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Togano T; Department of Haematology, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Asai Y; AMR Clinical Reference Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Matsunaga N; AMR Clinical Reference Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Terada M; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Ohtsu H; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Kitajima K; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Shimizu Y; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Sato L; Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Ishikane M; Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Kinoshita-Iwamoto N; Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Shibata T; Biostatistics Division, Centre for Research Administration and Support, National Cancer Centre, Tokyo, Japan.
  • Kondo M; Centre for Clinical Trial and Research Support, Fujita Health University, Aichi, Japan.
  • Izumi K; Biostatistics Section, Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Biostatistics Division, Centre for Research Administration and Support, National Cancer Centre, Tokyo, Japan.
  • Ohmagari N; Department of Haematology, National Centre for Global Health and Medicine, Tokyo, Japan; Biostatistics Division, Centre for Research Administration and Support, National Cancer Centre, Tokyo, Japan.
Int J Infect Dis ; 112: 111-116, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34517044
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article